دوره 11، شماره 2 - ( 12-1398 )
جلد 11 شماره 2 صفحات 206-201 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaeimanesh N, Sahraian M A, Naser Moghadasi A. Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms. BCN 2020; 11 (2) :201-206
URL: http://bcn.iums.ac.ir/article-1-1763-fa.html
URL: http://bcn.iums.ac.ir/article-1-1763-fa.html
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms. مجله علوم اعصاب پایه و بالینی. 1398; 11 (2) :201-206
چکیده:
Introduction: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed.
Methods: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week.
Results: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%).
Conclusion: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself.
Methods: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week.
Results: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%).
Conclusion: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself.
نوع مطالعه: Commentary |
موضوع مقاله:
Behavioral Neuroscience
دریافت: 1399/2/6 | پذیرش: 1399/3/24 | انتشار: 1399/3/25
دریافت: 1399/2/6 | پذیرش: 1399/3/24 | انتشار: 1399/3/25
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
